NCT04187417View on ClinicalTrials.gov

Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2018

Conditions
Corneal Abrasion
Interventions
DRUG

topical tetracaine hydrochloride 1%

topical ophthalmologic anesthestic

DRUG

Placebo

Placebo

All Listed Sponsors
lead

INTEGRIS Southwest Medical Center

OTHER

NCT04187417 - Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions | Biotech Hunter | Biotech Hunter